|
|
Bonnie J. Deroo, Kenneth S. Korach
J Clin Invest. 2006;
116(3):561
doi:10.1172/JCI27987
Abstract |
Full text
| PDF
| Supplemental material
E
strogens influence many physiological processes in mammals, including but not limited to reproduction, cardiovascular health, bone integrity, cognition, and behavior. Given this widespread role for estrogen in human physiology, it is not surprising that estrogen is also implicated in the development or progression of numerous diseases, which include but are not limited to various types of cancer (breast, ovarian, colorectal, prostate, endometrial), osteoporosis, neurodegenerative diseases, cardiovascular disease, insulin resistance, lupus erythematosus, endometriosis, and obesity. In many of these diseases, estrogen mediates its effects through the estrogen receptor (ER), which serves as the basis for many therapeutic interventions. This Review will describe diseases in which estrogen, through the ER, plays a role in the development or severity of disease.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(29)
| Title and authors |
Publication |
Year |
Oestrogen Signalling and Neuroprotection in Cerebral Ischaemia : Oestrogen neuroprotection
D. Brann, L. Raz, R. Wang, R. Vadlamudi, Q. Zhang
|
Journal of Neuroendocrinology
|
2012 |
The effects of conjugated estrogen, raloxifene and soy extract on collagen in rat bones
F. L. F. Condi, J. M. Soares, W. R. Teodoro, A. P. Veloso, E. R. Parra, M. de Jesus Simoes, E. C. Baracat
|
Climacteric
|
2012 |
Importance of oestrogen receptors to preserve functional β-cell mass in diabetes
Joseph P. Tiano, Franck Mauvais-Jarvis
|
Nat Rev Endocrinol
|
2012 |
MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells
Rosamaria Lappano, Maria Santolla, Marco Pupo, Maria Sinicropi, Anna Caruso, Camillo Rosano, Marcello Maggiolini
|
Breast Cancer Res
|
2012 |
Potential Value of Estrogen Receptor Beta Expression in Colorectal Carcinoma: Interaction with Apoptotic Index
Hosam Ghazy Elbanna, Mohamed Awad Ebrahim, Amr Medhat Abbas, Khaled Zalata, Maha Abo Hashim
|
J Gastrointest Canc
|
2012 |
Autoantibodies to estrogen receptor α interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus
Tania Colasanti, Angela Maselli, Fabrizio Conti, Massimo Sanchez, Cristiano Alessandri, Cristiana Barbati, Davide Vacirca, Antonella Tinari, Flavia Chiarotti, Antonello Giovannetti
|
Arthritis Rheum
|
2012 |
Using bazedoxifene plus conjugated estrogens for treating postmenopausal women : a comprehensive review
Hugh S. Taylor, Kathleen Ohleth
|
Menopause
|
2012 |
Estrogen receptor α36 mediates a bone-sparing effect of 17β-estrodiol in postmenopausal women
Hui Xie, Mei Sun, Xiao-Bo Liao, Ling-Qing Yuan, Zhi-Feng Sheng, Ji-Cai Meng, Dan Wang, Zhi-Yong Yu, Lei-Yi Zhang, Hou-De Zhou, Xiang-Hang Luo, Hui Li, Xian-Ping Wu, Qi-You Wei, Si-Yuan Tang, Zhao-Yi Wang, Er-Yuan Liao
|
J Bone Miner Res
|
2011 |
The G-protein-coupled estrogen receptor GPER in health and disease
Eric R. Prossnitz, Matthias Barton
|
Nat Rev Endocrinol
|
2011 |
Regulation of FoxO transcription factors by acetylation and protein–protein interactions
Hiroaki Daitoku, Jun-ichi Sakamaki, Akiyoshi Fukamizu
|
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
|
2011 |
|